Trevena
-
Chesterbrook-based Trevena Reduces Workforce, Continues to Evaluate Future Options
Chesterbrook-based Trevena, which was delisted from NASDAQ last month, has brought its workforce down to four full-time employees and is currently evaluating the options for…
-
Chesterbrook-Based Biopharmaceutical Company on Track for Massive Windfall
Trevena, a biopharmaceutical company based in Chesterbrook, has entered into a royalty-based financing deal with an affiliate of R-Bridge Healthcare Fund that could lead to a…
-
Chesterbrook-Based Trevena Receives Milestone Payment from Licensing Partner in China
After the FDA approved its new pain medication, Olinvyk, earlier this month, Chesterbrook-based Trevena has received a $3 million milestone payment from its licensing partner…
-
Chesterbrook-Based Trevena’s Stock Surges After FDA Approves New Pain Med
Chesterbrook-based Trevena saw its stock surge by 50 percent after the FDA approved its new pain medicine on Monday, writes John George for the Philadelphia…
-
Pair of Chester County Companies Working on Potential COVID-19 Treatments
Chesterbrook-based Trevena and Wayne-based Aclaris Therapeutics have joined the growing list of drug developers currently working on potential COVID-19 treatments, writes John George for the…
-
If at First You Don’t Succeed … Chesterbrook-Based Trevena Tries Again with Experimental Opioid
Chesterbrook-based Trevena has refiled its drug application to the Food and Drug Administration for IV oliceridine, an opioid pain relief medicine with fewer side effects…
-
Rapidly Growing Trevena to Move Headquarters from King of Prussia to Wayne
Trevena, a rapidly growing biopharmaceutical company, is about to become the newest tenant in Wayne’s Chesterbrook Corporate Center after signing a 10-year lease on 40,565…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
